1 | Ablation of remnant tissue | Appropriate | 8 |
2 | Adjuvant 131I treatment | Appropriate | 8 |
3 | Treatment of regional and distant metastatic disease | Appropriate | 9 |
4 | Treatment of patients with thyroid cancer who have had no prior thyroidectomy | Rarely appropriate | 3 |
5 | Thyroid cancer in patient with hemithyroidectomy and remaining residual functioning of thyroid lobe | May be appropriate | 4 |
6 | Abnormal Tg (or elevated anti-TgAb) level – no evidence of IA thyroid tissue on whole-body imaging with radioiodine | May be appropriate | 5 |
7 | Abnormal Tg (or elevated anti-TgAb) level in patients with no prior response to 131I therapy | May be appropriate | 4 |
8 | Patient with history of DTC, uncharacterized new suspicious lesion | Rarely appropriate | 2 |
9 | Anaplastic thyroid carcinoma | Rarely appropriate | 1 |
10 | MTC | Rarely appropriate | 1 |
11 | 18F-FDG PET/CT shows 18F-FDG-avid lesion | May be appropriate | 5 |
12 | Residual IA thyroid tissue documented with radioiodine imaging after total or near-total thyroidectomy in pregnant or lactating patients | Rarely appropriate | 1 |
13 | Pregnant or lactating patients | Rarely appropriate | 1 |